|
Apr 29
|
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 29
|
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
|
|
Apr 28
|
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
|
|
Mar 14
|
Why Ocular Therapeutix Was Bumping Higher This Week
|
|
Mar 11
|
Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside
|